Medicated Shampoo Market - Forecast(2025 - 2031)

Medical Shampoo Market Overview

The Medicated Shampoo Market is estimated to reach US$21.2 billion by 2031, growing at a CAGR of 5.0% from 2025 to 2031. Shampoos contain drugs to treat skin conditions on the scalp, such as dandruff, lice, or fungal infections. They can help reduce inflammation and itchiness. Growing widespread scalp and hair disorders, increasing hair loss concerns, rising dermatological recommendations for organic Medicated Shampoos, rising consumer awareness, and developing product innovations with regulatory approvals are some of the major drivers for the Medicated Shampoo Market. 

Recent trends in the Medicated Shampoo Market highlight the rise in demand for organic Medicated Shampoos and growing product innovations in formulations and ingredients. In November 2024, CeraVe launched its First haircare product, which is said to have been developed with dermatologists. CeraVe Anti-Dandruff Shampoo and Conditioner also mentioned eliminating up to 100% of visible flakes while preserving the scalp barrier, soothing mild to moderate dandruff, and keeping hair soft and healthy.  Additionally, it is considered to be a revolutionary approach that targets the root cause of dandruff and ceramide deficiency while respecting the delicacy of the scalp barrier. The range also includes the new Anti-Dandruff Shampoo, which is formulated with 1% Pyrithione Zinc, and effectively helps eliminate up to 100% of visible flakes when regularly used as a system with the Anti-Dandruff Conditioner for all hair types. 

Market Snapshot:

Medicated Shampoo Market - Report Coverage:

The report: “Medicated Shampoo Market – Forecast (2025-2031)”, by IndustryARC, covers an in-depth analysis of the following segments of the Medicated Shampoo Industry. 

Key Takeaways:

Anti-Dandruff Shampoo is the Largest Segment

The Anti-Dandruff segment holds the largest share in the market in 2024. The anti-dandruff shampoo market leads the Medicated Shampoo industry, driven by the increasing instances of dandruff and seborrheic dermatitis. In October 2023, according to the Department of Health, State Government of Victoria, Australia, about 50 % of the population suffers from dandruff at some point in their life and regular washing with an anti-dandruff shampoo is useful in the treatment of dandruff. Additionally, unlike other Medicated Shampoos, anti-dandruff formulations are used regularly, which ensures consistent demand and repeat purchases. The rise of natural and herbal anti-dandruff shampoos like tea tree oil and salicylic acid further expands the market. With increasing scalp health awareness and dermatologist recommendations, anti-dandruff shampoos remain the fastest-growing and most widely used Medicated Shampoo category globally.

Ketoconazole is the Largest Segment

Ketoconazole holds the largest share in the market with a CAGR of 42.5% in the forecast period of 2025 to 2031. Ketoconazole is the largest ingredient in the Medicated Shampoo market for its strong antifungal properties that effectively treat dandruff, seborrheic dermatitis, and scalp infections. Ketoconazole is said to be targeting Malassezia, a yeast responsible for scalp irritation, making it a preferred choice for dermatologists and consumers. According to the Cleveland Clinic, Ketoconazole treats fungal or yeast infections of the skin. It may also be used to treat seborrheic dermatitis, a condition that causes dry, flaky, and itchy skin. It belongs to a group of medications called antifungals.  Additionally, in August 2024, according to the National Institutes of Health, ketoconazole had 73% improvement in dandruff severity whereas it was 67% in zinc pyrithione. The recurrence of Seborrheic Dermatitis or severe dandruff was also significantly lower with ketoconazole.

North America Leads the Market

North America dominates the Medicated Shampoo market driven by high consumer awareness and a strong focus on scalp health and hygiene. Another reason the region holds the largest is due to the widespread scalp conditions like dandruff, seborrheic dermatitis, and hair loss, growing the demand for effective medicated solutions. In March 2024, Dr.FORHAIR, a global scalp care brand sold 18,000 units of Folligen Original Shampoo at 50 U.S. locations within just 3 weeks of its first offline launch of the product which was rated a 99.9% satisfaction rate for improvements in odor, oily, forelock, side hair volume, and cleanliness by the consumers. It is also been observed that consumers in North America are increasingly preferring dermatologist-recommended products like zinc pyrithione, ketoconazole, and coal tar-based shampoos.

Widespread Conditions of Hair and Scalp Disorders to Drive the Market

Rising conditions such as dandruff, seborrheic dermatitis, psoriasis, eczema, and fungal infections affect millions globally, increasing demand for specialized treatments. Additionally, factors like pollution, stress, hormonal imbalances, and poor scalp hygiene contribute to these issues, prompting consumers to seek clinically proven solutions. The growing awareness of scalp health, combined with dermatologist recommendations, has led to increased adoption of both prescription and over-the-counter (OTC) Medicated Shampoos. Medicated shampoos formulated with zinc pyrithione, ketoconazole, coal tar, and salicylic acid are said to be treated effectively for some scalp conditions, offering relief from itching, flaking, and inflammation. As hair and scalp disorders become more widespread, the market for Medicated Shampoos is expected to expand significantly. According to the statistical data of the National Psoriasis Foundation, USA, 125 million people worldwide, that is 2-3% of the total population have psoriasis. 

 

For More Details on This Report - Request for Sample

Medicated Shampoo Market Key Players

The top 10 players in the Medicated Shampoo Market are:

1.    Procter & Gamble
2.    Unilever
3.    Johnson & Johnson
4.    Henkel AG & Co. KGaA
5.    Kao Corporation
6.    Himalaya Wellness Company
7.    Summers Laboratories, Inc
8.    Sanofi Consumer Healthcare
9.    Kramer Laboratories
10.    Shiseido Company

Scope of the Report:

For more Consumer Products and Services Market reports, please click here